Sleep apnoea and the hypothalamic-pituitary-adrenal axis in men and women: Effects of continuous positive airway pressure

European Respiratory Journal

Volumn 47, Issue 2, 2016, Pages 531-540

  Kritikou, Ilia ^a   Basta, Maria ^a,b   Vgontzas, Alexandros N ^a   Pejovic, Slobodanka ^a   Fernandez Mendoza, Julio ^a   Liao, Duanping ^a   Bixler, Edward O ^a   Gaines, Jordan ^a   Chrousos, George P ^c  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CRETE   (Greece)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE;

ADULT; ARTICLE; BECK ANXIETY INVENTORY; BLOOD PRESSURE; BODY MASS; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DEPRESSION; EMOTIONAL STRESS; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; POSITIVE END EXPIRATORY PRESSURE; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SLEEP DISORDERED BREATHING; AGED; ANXIETY; CASE CONTROL STUDY; CIRCADIAN RHYTHM; COMPLICATION; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; HYPERTENSION; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; HYPOXIA; MENTAL STRESS; METABOLISM; OBESITY; PROCEDURES; PSYCHOLOGY; SLEEP APNEA, OBSTRUCTIVE; SLEEP DEPRIVATION; TREATMENT OUTCOME;

ADULT; AGED; ANXIETY; BLOOD PRESSURE; CASE-CONTROL STUDIES; CIRCADIAN RHYTHM; CONTINUOUS POSITIVE AIRWAY PRESSURE; CROSS-OVER STUDIES; DEPRESSION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYDROCORTISONE; HYPERTENSION; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; HYPOXIA; MALE; MIDDLE AGED; OBESITY; PITUITARY-ADRENAL SYSTEM; SLEEP APNEA, OBSTRUCTIVE; SLEEP DEPRIVATION; STRESS, PSYCHOLOGICAL; TREATMENT OUTCOME;

EID: 84958073752     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/13993003.00319-2015     Document Type: Article

References (33)

1. Vgontzas AN, Kales A. Sleep and its disorders. Annu Rev Med 1999; 50: 387-400.
2. Späth-Schwalbe E, Gofferje M, Kern W, et al. Sleep disruption alters nocturnal ACTH and cortisol secretory patterns. Biol Psychiatry 1991; 29: 575-584.
3. Lanfranco F, Gianotti L, Pivetti S, et al. Obese patients with obstructive sleep apnoea syndrome show a peculiar alteration of the corticotroph but not of the thyrotroph and lactotroph function. Clin Endocrinol (Oxf) 2004; 60: 41-48.
4. Panaree B, Chantana M, Wasana S, et al. Effects of obstructive sleep apnea on serum brain-derived neurotrophic factor protein, cortisol, and lipid levels. Sleep Breath 2011; 15: 649-656.
5. Lam JC, Yan CS, Lai AY, et al. Determinants of daytime blood pressure in relation to obstructive sleep apnea in men. Lung 2009; 187: 291-298.
6. Barceló A, Barbé F, de la Peña M, et al. Insulin resistance and daytime sleepiness in patients with sleep apnoea. Thorax 2008; 63: 946-950.
7. Grunstein RR, Handelsman DJ, Lawrence SJ, et al. Neuroendocrine dysfunction in sleep apnea: reversal by continuous positive airways pressure therapy. J Clin Endocrinol Metab 1989; 68: 352-358.
8. Nakamura T, Chin K, Shimizu K, et al. Acute effect of nasal continuous positive airway pressure therapy on the systemic immunity of patients with obstructive sleep apnea syndrome. Sleep 2001; 24: 545-553.
9. Karaca Z, Ismailogullari S, Korkmaz S, et al. Obstructive sleep apnoea syndrome is associated with relative hypocortisolemia and decreased hypothalamo-pituitary-adrenal axis response to 1 and 250 μg ACTH and glucagon stimulation tests. Sleep Med 2013; 14: 160-164.
10. Bratel T, Wennlund A, Carlström K. Pituitary reactivity, androgens and catecholamines in obstructive sleep apnoea. Effects of continuous positive airway pressure treatment (CPAP). Respir Med 1999; 93: 1-7.
11. Vgontzas AN, Pejovic S, Zoumakis E, et al. Hypothalamic-pituitary-adrenal axis activity in obese men with and without sleep apnea: effects of continuous positive airway pressure therapy. J Clin Endocrinol Metab 2007; 92: 4199-4207.
12. Edwards KM, Kamat R, Tomfohr LM, et al. Obstructive sleep apnea and neurocognitive performance: the role of cortisol. Sleep Med 2014; 15: 27-32.
13. Tomfohr LM, Edwards KM, Dimsdale JE. Is obstructive sleep apnea associated with cortisol levels? A systematic review of the research evidence. Sleep Med Rev 2012; 16: 243-249.
14. Carneiro G, Togeiro SM, Hayashi LF, et al. Effect of continuous positive airway pressure therapy on hypothalamic-pituitary-adrenal axis function and 24-h blood pressure profile in obese men with obstructive sleep apnea syndrome. Am J Physiol Endocrinol Metab 2008; 295: E380-E384.
15. Henley DE, Russell GM, Douthwaite JA, et al. Hypothalamic-pituitary-adrenal axis activation in obstructive sleep apnea: the effect of continuous positive airway pressure therapy. J Clin Endocrinol Metab 2009; 94: 4234-4242.
16. Meston N, Davies RJ, Mullins R, et al. Endocrine effects of nasal continuous positive airway pressure in male patients with obstructive sleep apnoea. J Intern Med 2003; 254: 447-454.
17. Schmoller A, Eberhardt F, Jauch-Chara K, et al. Continuous positive airway pressure therapy decreases evening cortisol concentrations in patients with severe obstructive sleep apnea. Metabolism 2009; 58: 848-853.
18. Kritikou I, Basta M, Tappouni R, et al. Sleep apnoea and visceral adiposity in middle-aged male and female subjects. Eur Respir J 2013; 41: 601-609.
19. Kritikou I, Basta M, Vgontzas AN, et al. Sleep apnea, sleepiness, inflammation and insulin resistance in middle-aged men and women. Eur Respir J 2014; 43: 145-155.
20. Chrousos GP. Stress and disorders of the stress system. Nat Rev Endocrinol 2009; 5: 374-381.
21. Gaines J, Vgontzas AN, Fernandez-Mendoza J, et al. Gender differences in the association of sleep apnea and inflammation. Brain Behav Immun 2015; 47: 211-217.
22. Basta M, Lin HM, Pejovic S, et al. Lack of regular exercise, depression, and degree of apnea are predictors of excessive daytime sleepiness in patients with sleep apnea: sex differences. J Clin Sleep Med 2008; 4: 19-25.
23. Quintana-Gallego E, Carmona-Bernal C, Capote F, et al. Gender differences in obstructive sleep apnea syndrome: a clinical study of 1166 patients. Respir Med 2004; 98: 984-989.
24. Habukawa M, Uchimura N, Kakuma T, et al. Effect of CPAP treatment on residual depressive symptoms in patients with major depression and coexisting sleep apnea: contribution of daytime sleepiness to residual depressive symptoms. Sleep Med 2010; 11: 552-557.
25. Gagnadoux F, Le Vaillant M, Goupil F, et al. Depressive symptoms before and after long-term CPAP therapy in patients with sleep apnea. Chest 2014; 145: 1025-1031.
26. Means MK, Lichstein KL, Edinger JD, et al. Changes in depressive symptoms after continuous positive airway pressure treatment for obstructive sleep apnea. Sleep Breath 2003; 7: 31-42.
27. Schwartz DJ, Kohler WC, Karatinos G. Symptoms of depression in individuals with obstructive sleep apnea may be amenable to treatment with continuous positive airway pressure. Chest 2005; 128: 1304-1309.
28. Ye L, Pien GW, Ratcliffe SJ, et al. Gender differences in obstructive sleep apnea and treatment response to continuous positive airway pressure. J Clin Sleep Med 2009; 5: 512-518.
29. Alajmi M, Mulgrew AT, Fox J, et al. Impact of continuous positive airway pressure therapy on blood pressure in patients with obstructive sleep apnea hypopnea: a meta-analysis of randomized controlled trials. Lung 2007; 185: 67-72.
30. Montesi SB, Edwards BA, Malhotra A, et al. The effect of continuous positive airway pressure treatment on blood pressure: a systematic review and meta-analysis of randomized controlled trials. J Clin Sleep Med 2012; 8: 587-596.
31. Pépin JL, Tamisier R, Barone-Rochette G, et al. Comparison of continuous positive airway pressure and valsartan in hypertensive patients with sleep apnea. Am J Respir Crit Care Med 2010; 182: 954-960.
32. Vgontzas AN, Zoumakis E, Bixler EO, et al. Selective effects of CPAP on sleep apnoea-associated manifestations. Eur J Clin Invest 2008; 38: 585-595.
33. Kohler M, Ayers L, Pepperell JC, et al. Effects of continuous positive airway pressure on systemic inflammation in patients with moderate to severe obstructive sleep apnoea: a randomised controlled trial. Thorax 2009; 64: 67-73.